IV Flush Syringe Sales

IV Flush Syringe Sales Market Outlook

The global IV flush syringe market is poised for substantial growth, expected to reach approximately USD 2.5 billion by 2035, with a compound annual growth rate (CAGR) of around 6% during the forecast period of 2025–2035. This growth can be attributed to the increasing prevalence of chronic diseases, the aging population, and a rising number of surgical procedures that require effective venous access. Moreover, the heightened awareness about infection control and the need for safe and efficient medication administration practices are significantly fueling the adoption of IV flush syringes in various healthcare settings. The evolving healthcare landscape, alongside technological advancements in IV delivery systems, is anticipated to create a favorable environment for the growth of this market. Additionally, strategic initiatives by key players to enhance product offerings and improve distribution channels are expected to contribute to the overall market expansion.

Growth Factor of the Market

The IV flush syringe market is experiencing growth driven by several factors, including the increasing incidences of hospital-acquired infections (HAIs) and the consequent emphasis on maintaining stringent infection control protocols. As healthcare providers strive to enhance patient safety, the demand for pre-filled flush syringes that ensure accurate dosing and sterility is on the rise. Additionally, the growing number of outpatient and home healthcare settings is propelling the need for user-friendly IV flush syringes, enabling easy administration by non-medical professionals. Moreover, the expanding geriatric population, which often requires continuous intravenous therapy, is another significant driver for the market. The advent of innovative flushing systems, including safety syringes and specialized flush solutions, is also noteworthy, as they cater to the evolving needs of healthcare providers and enhance overall patient outcomes.

Key Highlights of the Market

• The market is projected to grow at a CAGR of 6% from 2025 to 2035.
• Pre-filled IV flush syringes are gaining popularity due to their convenience and reduced risk of contamination.
• North America holds a significant market share, driven by advanced healthcare infrastructure.
• Online pharmacies are emerging as a vital distribution channel, providing wider access to consumers.
• The increasing emphasis on safety features in syringe design is enhancing product adoption rates.

By Product Type

Pre-filled IV Flush Syringes:

Pre-filled IV flush syringes are becoming increasingly popular within the healthcare sector due to their convenience and assured sterility. They contain pre-measured doses of saline or other flushing solutions, which eliminates the need for healthcare professionals to prepare syringes manually. This not only saves time but also minimizes the risk of contamination and dosing errors, thereby enhancing patient safety. The growing trend towards automation in healthcare settings and the rising emphasis on infection control are propelling the demand for pre-filled syringes. Moreover, manufacturers are focusing on developing innovative solutions that cater to specific clinical needs, thus driving the evolution of pre-filled IV flush syringe products.

Non-filled IV Flush Syringes:

Non-filled IV flush syringes serve as an essential component in various medical settings, primarily used for the manual preparation of flush solutions. These syringes provide healthcare professionals with the flexibility to customize the volume and type of flushing solution as per the patient's needs. The demand for non-filled syringes is particularly prevalent in hospitals and clinics where personalized patient care is emphasized. As healthcare providers continue to seek solutions that offer both efficiency and adaptability in treatment protocols, non-filled IV flush syringes are projected to maintain steady growth within the market.

Safety IV Flush Syringes:

Safety IV flush syringes are specifically designed to minimize the risk of needle-stick injuries, which are a significant concern in healthcare environments. These syringes incorporate features such as retractable needles and safety shields that aid in protecting healthcare professionals during administration. The increasing focus on workplace safety and regulations regarding needle disposal are driving the adoption of safety IV flush syringes. Moreover, with healthcare facilities prioritizing employee safety, the demand for these syringes is expected to rise significantly, bolstered by new product innovations aimed at enhancing usability and safety.

Specialty IV Flush Syringes:

Specialty IV flush syringes represent a niche segment of the market, tailored to specific medical applications such as chemotherapy or pediatric care. These syringes are equipped with unique formulations that cater to the specialized requirements of different patient populations. As the healthcare industry continues to evolve, the demand for tailored solutions is on the rise, driving the growth of specialty IV flush syringes. These products not only improve treatment efficacy but also enhance patient comfort, making them an integral part of modern healthcare delivery.

Bulb Syringe IV Flush:

Bulb syringe IV flushes offer a different mechanism for administering flush solutions, providing a manual, squeeze-action method. They are particularly useful in settings where precise control over the flushing process is necessary. The ease of use and versatility of bulb syringes make them an appealing option for healthcare professionals, especially in homecare settings and outpatient facilities. As the trend towards more patient-centric care continues, bulb syringe IV flushes can expect to gain traction due to their simplicity and effectiveness in various applications.

By Application

Hospitals:

The hospital segment represents a substantial share of the IV flush syringe market, driven by the high volume of intravenous therapies administered daily. With the increasing number of patients requiring IV access for medication delivery, hydration, and blood transfusions, hospitals are key consumers of IV flush syringes. The need for strict adherence to infection control protocols and the efficient management of venous access devices further propel the demand within this segment. Additionally, hospitals are increasingly adopting automated systems that incorporate advanced flush syringes, enhancing patient safety and care quality in critical care settings.

Clinics:

Clinics are gradually becoming significant consumers of IV flush syringes, thanks to the rising trend of outpatient and same-day discharge procedures. These facilities often require efficient and effective flushing systems for a variety of treatments, including minor surgeries and intravenous medication administration. The demand for IV flush syringes in clinics is influenced by the growing focus on outpatient care, which is expected to continue rising as healthcare costs become more important. As clinics prioritize patient comfort and streamlined operations, the adoption of IV flush syringes is anticipated to increase in this segment.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are witnessing a growing demand for IV flush syringes due to the increasing number of outpatient procedures being performed. These centers focus on providing high-quality surgical services in a more streamlined setting, which requires effective IV management. The emphasis on minimizing hospital stays and reducing healthcare costs drives ASC reliance on IV flush syringes. Moreover, the convenience and efficiency of using IV flush syringes align with the operational goals of ASCs, reinforcing their presence in this segment.

Homecare Settings:

Homecare settings are emerging as a crucial market segment for IV flush syringes, primarily driven by the increased adoption of home healthcare services. As healthcare trends shift towards patient-centered care, many patients now require IV therapy in the comfort of their homes. The usage of IV flush syringes in homecare promotes safety and ease of use for caregivers administering treatments. The growth of telehealth and remote monitoring technologies further supports the need for reliable IV flush solutions in homecare environments, significantly enhancing patient outcomes and satisfaction.

Other Medical Facilities:

Other medical facilities, which include rehabilitation centers and long-term care facilities, are also contributing to the overall demand for IV flush syringes. In these settings, intravenous therapies are frequently used for hydration and medication administration, necessitating efficient flushing systems. These facilities are increasingly adopting IV flush syringes due to their efficacy and ease of use, promoting better patient care. The growing recognition of the importance of infection control and effective medication delivery in all medical environments amplifies the demand for IV flush syringes, reinforcing their significance across various healthcare sectors.

By Distribution Channel

Hospitals Pharmacies:

Hospital pharmacies play a pivotal role in the distribution of IV flush syringes, as they are the primary source for healthcare providers within hospital settings. These pharmacies focus on meeting the specific needs of healthcare professionals by ensuring a consistent supply of essential medical products, including IV flush syringes. The integration of technology in hospital pharmacies streamlines inventory management and enhances procurement efficiency, enabling quicker access to flush syringes when needed. Furthermore, as hospitals increasingly prioritize patient safety and quality care, the demand for IV flush syringes obtained through hospital pharmacies is expected to grow.

Retail Pharmacies:

Retail pharmacies are becoming more significant in the distribution of IV flush syringes, particularly as the demand for home healthcare solutions continues to rise. Many patients requiring IV therapy are now seeking to procure their supplies through retail channels, leading to the expansion of IV flush syringe offerings in these establishments. Retail pharmacies are adapting to this trend by providing a wider range of products, including pre-filled and non-filled syringes, and offering educational resources for patients and caregivers. The convenience of accessibility in retail pharmacies enhances the overall patient experience and drives the growth of the IV flush syringe market through this channel.

Online Pharmacies:

The emergence of online pharmacies has revolutionized the distribution landscape for IV flush syringes, providing a convenient and accessible option for consumers. With an increasing number of patients turning to e-commerce for their healthcare needs, online pharmacies are optimizing their platforms to offer a comprehensive range of IV flush syringes. The ability to compare prices, read reviews, and access educational materials enhances the consumer experience, driving demand in this segment. As online pharmacies continue to expand their offerings and improve their logistics, they are likely to play a crucial role in the growth of the IV flush syringe market.

Direct Sales:

Direct sales channels represent an important avenue for IV flush syringe distribution, allowing manufacturers to establish direct relationships with healthcare providers. Through direct sales, manufacturers can ensure that their products meet the specific needs of their clients, which can lead to higher customer satisfaction and loyalty. This channel is particularly beneficial in B2B transactions where healthcare institutions require bulk orders of IV flush syringes. As manufacturers focus on enhancing customer engagement and support, the direct sales channel is poised to experience growth in the coming years.

Other Distribution Channels:

Other distribution channels, which include specialty distributors and third-party logistics providers, are becoming increasingly relevant in the IV flush syringe market. These channels often provide tailored solutions to healthcare facilities, ensuring timely delivery and efficient inventory management. Specialty distributors can offer unique products and customization options that may not be available through traditional channels. As the healthcare landscape evolves, the importance of diversified distribution strategies will grow, enabling manufacturers to reach a wider audience and enhance their market presence through various distribution networks.

By Ingredient Type

Sodium Chloride:

Sodium chloride is a widely used ingredient in IV flush syringes due to its effectiveness as a isotonic solution for maintaining fluid balance in patients. It is commonly used for flushing IV lines to prevent clotting and maintain patency. The demand for sodium chloride-based flush syringes is driven by the high volume of surgical and intravenous procedures performed in healthcare settings. As healthcare professionals continue to prioritize the safety and efficacy of intravenous therapies, sodium chloride remains a preferred choice for many IV flush applications, thereby reinforcing its significance in the market.

Heparin:

Heparin-based IV flush syringes are specifically designed to prevent clot formation within IV catheters, making them essential in settings where patients require long-term venous access. The use of heparin is particularly prevalent in critical care and oncology departments, where maintaining catheter patency is crucial for patient treatment regimens. The increasing prevalence of chronic conditions that necessitate prolonged intravenous therapies is driving the demand for heparin flush syringes. As healthcare providers continue to seek solutions that enhance patient care and reduce complications, heparin remains a vital ingredient in the IV flush syringe market.

Normal Saline:

Normal saline is another common ingredient used in IV flush syringes, providing a safe and effective means of flushing IV lines and maintaining hydration in patients. It is particularly beneficial in emergency medicine and inpatient care where rapid administration of fluids is essential. The growing emphasis on patient safety and infection control practices is driving the demand for normal saline flush syringes, as they facilitate accurate dosing and minimize the risk of contamination. The versatility of normal saline in various clinical applications further boosts its popularity, solidifying its role in the IV flush syringe market.

Sterile Water:

Sterile water is used in IV flush syringes for diluting medications and flushing IV lines in specific therapeutic scenarios. Its demand is driven by the need for high-quality, sterile solutions that ensure patient safety during intravenous administration. Healthcare providers often utilize sterile water as a diluent for various injectable medications, making it a valuable component in IV therapy. The increasing awareness of infection prevention and the need for reliable flushing solutions contribute to the growth of sterile water-based IV flush syringes in the market.

Sodium Bicarbonate:

Sodium bicarbonate is used in specialized IV flush syringes, particularly in cases where there is a need to maintain a neutral pH or counteract acidosis. It is often utilized in critical care settings and among patients undergoing specific medical treatments. The growing recognition of the importance of pH balance in patient care is driving the demand for sodium bicarbonate flush syringes. As healthcare practices evolve, sodium bicarbonate's role in IV therapy is expected to grow, supporting its inclusion in the IV flush syringe market.

By Region

North America is anticipated to dominate the IV flush syringe market, accounting for roughly 40% of the global market share by 2035. The region is characterized by advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a significant emphasis on patient safety and infection control practices. The ongoing growth of outpatient and home healthcare services is further fueling the demand for IV flush syringes in North America. Additionally, the presence of major players in the region contributes to a competitive landscape that encourages continuous innovation and product development.

Europe is also expected to witness significant growth in the IV flush syringe market, with a projected CAGR of approximately 5.5% between 2025 and 2035. The European market benefits from a robust healthcare system and increasing awareness regarding the importance of infection prevention in medical settings. Countries such as Germany, France, and the UK are at the forefront of adopting advanced IV delivery systems and flush solutions. The rising incidences of chronic diseases, combined with an aging population, further drive the demand for IV flush syringes in Europe, establishing it as a key player in the global market.

Opportunities

The IV flush syringe market presents several opportunities for growth, particularly in the realm of product innovation. As healthcare providers continually seek solutions that enhance patient safety and treatment efficacy, manufacturers can capitalize on developing advanced flush syringe technologies. Innovations such as safety features, pre-filled options, and specialized formulations tailored to specific clinical needs have the potential to capture a significant share of the market. Additionally, the increasing trend of home healthcare provides a unique opportunity for manufacturers to introduce user-friendly flush syringe products that cater to non-professional caregivers. By addressing the evolving needs of the healthcare landscape, companies can enhance their product offerings and strengthen their market foothold.

Moreover, expanding distribution channels, particularly online pharmacies and direct sales, can further enhance market reach and accessibility of IV flush syringes. As patients and healthcare providers increasingly turn to e-commerce for their medical supplies, manufacturers must prioritize partnerships with online platforms to ensure product availability. Furthermore, collaboration with healthcare facilities to provide bulk purchasing options can create mutually beneficial arrangements, expanding market penetration. Ultimately, embracing these opportunities will empower companies to position themselves strategically within the IV flush syringe market and capitalize on the growing demand for effective intravenous therapy solutions.

Threats

The IV flush syringe market faces several threats that could impact its growth trajectory. One of the primary concerns is the potential for regulatory changes that may impose stringent guidelines on the manufacturing and distribution of medical devices. Compliance with evolving regulations can be challenging for companies, particularly smaller manufacturers that may lack the resources to adapt quickly. Additionally, competition from alternative infusion methods and devices, such as automated infusion pumps, poses a threat to the traditional IV flush syringe market. As technology continues to advance, healthcare providers may gravitate towards these alternatives, which could result in a decline in demand for conventional flush syringes.

Another significant threat is the risk of contamination and infection associated with improper use of IV flush syringes. Despite efforts to enhance safety measures, incidents of hospital-acquired infections stemming from IV access procedures remain a concern. As healthcare providers prioritize patient safety, any reports of adverse events linked to IV flush syringes could lead to diminished trust in these products. Manufacturers must remain vigilant in maintaining high-quality standards and educating healthcare professionals about proper usage techniques to mitigate these risks and preserve the integrity of the IV flush syringe market.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Medtronic plc
• Cardinal Health
• Terumo Corporation
• Smiths Medical
• Fresenius Kabi AG
• B. Braun Melsungen AG
• Halyard Health, Inc.
• West Pharmaceutical Services, Inc.
• Gerresheimer AG
• Medline Industries, Inc.
• Vygon SA
• Owen Mumford Ltd.
• Amcor plc
• Savvy Medical Supplies

The IV flush syringe market is characterized by a competitive landscape with numerous key players striving to enhance their presence and product offerings. Companies are increasingly investing in research and development to create innovative solutions that address the growing demand for safe and efficient intravenous therapies. Additionally, the focus on strategic partnerships and collaborations is becoming prevalent as firms seek to expand their market reach and improve supply chain efficiencies. As competition intensifies, players must prioritize quality, safety, and customer satisfaction to differentiate themselves in this dynamic environment.

Among the prominent players, BD (Becton, Dickinson and Company) stands out as a leader in the IV flush syringe market, with a comprehensive product portfolio that includes pre-filled and safety syringes. The company is renowned for its commitment to innovation and has invested heavily in developing advanced injection and infusion systems that enhance patient outcomes. Medtronic plc is another major player, leveraging its expertise in medical technology to offer solutions designed for efficient and safe intravenous therapy. With a strong emphasis on patient safety, Medtronic's products are widely recognized in the healthcare sector.

Cardinal Health has also established itself as a key competitor in the IV flush syringe market, providing a range of flushing solutions tailored to the needs of healthcare providers. The company's extensive distribution network and commitment to quality have enabled it to maintain a competitive edge in the industry. Similarly, Terumo Corporation and Smiths Medical have made significant strides in developing innovative IV delivery systems that cater to diverse clinical applications. Their focus on research and development has allowed them to introduce specialized products that enhance patient care and safety.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Vygon SA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Amcor plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smiths Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cardinal Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Gerresheimer AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fresenius Kabi AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Owen Mumford Ltd.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Terumo Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Halyard Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 B. Braun Melsungen AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Savvy Medical Supplies
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Medline Industries, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 West Pharmaceutical Services, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 IV Flush Syringe Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Homecare Settings
    • 6.1.5 Other Medical Facilities
  • 6.2 IV Flush Syringe Sales Market, By Product Type
    • 6.2.1 Pre-filled IV Flush Syringes
    • 6.2.2 Non-filled IV Flush Syringes
    • 6.2.3 Safety IV Flush Syringes
    • 6.2.4 Specialty IV Flush Syringes
    • 6.2.5 Bulb Syringe IV Flush
  • 6.3 IV Flush Syringe Sales Market, By Ingredient Type
    • 6.3.1 Sodium Chloride
    • 6.3.2 Heparin
    • 6.3.3 Normal Saline
    • 6.3.4 Sterile Water
    • 6.3.5 Sodium Bicarbonate
  • 6.4 IV Flush Syringe Sales Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies
    • 6.4.4 Direct Sales
    • 6.4.5 Other Distribution Channels

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 IV Flush Syringe Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global IV Flush Syringe Sales market is categorized based on

By Product Type

• Pre-filled IV Flush Syringes
• Non-filled IV Flush Syringes
• Safety IV Flush Syringes
• Specialty IV Flush Syringes
• Bulb Syringe IV Flush

By Application

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Other Medical Facilities

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Direct Sales
• Other Distribution Channels

By Ingredient Type

• Sodium Chloride
• Heparin
• Normal Saline
• Sterile Water
• Sodium Bicarbonate

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Medtronic plc
• Cardinal Health
• Terumo Corporation
• Smiths Medical
• Fresenius Kabi AG
• B. Braun Melsungen AG
• Halyard Health, Inc.
• West Pharmaceutical Services, Inc.
• Gerresheimer AG
• Medline Industries, Inc.
• Vygon SA
• Owen Mumford Ltd.
• Amcor plc
• Savvy Medical Supplies